Executive Summary
Across the nine filings, the India IPO Activity Monitor captures post-listing compliance activity rather than fresh IPO launches: most filings are monitoring agency reports, utilisation statements, and board approvals tied to recent SME and mainboard listings.
The dominant theme is slow deployment of IPO proceeds, with several issuers holding large unutilised balances (Quanto Agroworld ₹1,515.29 Cr unutilised, Shiprocket with no growth-capex deployment, Anand Seamless with 100% of its ₹2,551.68 lakh still unspent, Harikanta with ₹1,541.69 lakh parked in deposits). Operating performance is mixed: AhaSolar grew net sales about 86% YoY to ₹6,702.94 lakh and swung to profit, but cash fell sharply and operating cash flow was negative, while Scan Steels posted a headline net profit of ₹1,452.59 lakh that was largely propped up by other income (~₹1,194.80 lakh). Omnitech and Symbiotec report clean deviation-free utilisation, while Yatharth needed shareholder approval to extend its fund-deployment deadline to March 31, 2027, a signal that deployment timelines are slipping. Investors should treat unutilised proceeds and other-income-driven profits as the key items to verify, not headline growth.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: IPO
Tracking the trend? Catch up on the prior India IPO SEBI DRHP Activity Filings digest from November 04, 2026.
Investment Signals (10)
-
Q2 FY27 revenue ₹17,043.87 lakh, up 28% YoY, and net profit ₹1,452.59 lakh vs a loss of ₹24.73 lakh a year earlier, but other income of ~₹1,194.80 lakh supplied most of the profit [BEARISH on quality of earnings]
- AhaSolar Technologies ↓ (BULLISH)▲
H1 FY27 net sales ₹6,702.94 lakh, up ~86% YoY, with operating profit before other income turning positive at ₹65.19 lakh from a loss of ₹31.17 lakh
- AhaSolar Technologies ↓ (BEARISH)▲
Operating cash flow of ₹(240.45) lakh and cash falling to ₹46.86 lakh from ₹248.34 lakh while short-term borrowings doubled to ₹182.90 lakh
- Omnitech Engineering ↓ (BULLISH)▲
47.1% (₹1,851.50 mn) of ₹4,180 mn IPO proceeds utilised with no deviations, and a ₹20.96 mn issue-expense surplus reallocated transparently
- Quanto Agroworld ↓ (BEARISH)▲
Farm expansion ~56% deployed (₹853.22 Cr of ₹1,522.94 Cr), but distillation plant capex is at nil against ₹379.24 Cr and GCP at 2.2%
- Harikanta Overseas ↓ (BEARISH)▲
Plant & machinery at ₹0 utilised of ₹932.50 lakh and factory capex at ₹40 lakh of ₹540.35 lakh six months post-listing signal execution delay on the capex plan
- Anand Seamless ↓ (NEUTRAL)▲
None of the ₹2,551.68 lakh IPO proceeds were utilised as of September 30, 2026, though allotment was only on September 25, 2026, so this is early-stage rather than a red flag
- Yatharth Hospital ↓ (BEARISH)▲
Shareholders approved extending the fund-utilisation deadline to March 31, 2027, a deadline extension that confirms a material unutilised balance from the ₹569.71 crore IPO
- Shiprocket ↓ (NEUTRAL)▲
₹210.00 Cr of ₹885.50 Cr IPO proceeds used for debt repayment (HDFC ₹133.50 Cr, ICICI ₹76.50 Cr) with no spend on platform, marketing or technology, so the use-of-proceeds mix is shifting toward deleveraging
- Symbiotec Pharmalab ↓ (BULLISH)▲
Clean first-quarter CARE monitoring report on ₹150 Cr proceeds with no deviations and no cost revisions, supporting disclosure quality
Risk Flags (8)
- Quanto Agroworld/Distillation Plant Delay↓ [HIGH RISK]▼
Zero utilisation of ₹379.24 Cr earmarked for the distillation plant as of 30-09-2026, a material project-execution risk
- Quanto Agroworld/GCP Under-deployment↓ [HIGH RISK]▼
Only ₹10.22 Cr of ₹465.00 Cr general corporate purposes budget spent (~2.2%), with ₹1,515.29 Cr total unutilised
- Scan Steels/Earnings Quality↓ [MEDIUM RISK]▼
Other income of ~₹1,194.80 lakh vs ₹6.29 lakh a year earlier means most of the quarter's profit is non-operating; finance costs also rose to ₹242.15 lakh from ₹216.84 lakh
- AhaSolar/Liquidity↓ [HIGH RISK]▼
Cash down ~81% to ₹46.86 lakh from ₹248.34 lakh in six months with negative operating cash flow of ₹(240.45) lakh and short-term borrowings up ~112%
- Yatharth Hospital/Deployment Slippage↓ [MEDIUM RISK]▼
Utilisation deadline extended to March 31, 2027 and scope widened to all subsidiaries, a sign that original deployment timelines have not been met
- Harikanta Overseas/Capex Underutilisation↓ [MEDIUM RISK]▼
₹1,541.69 lakh of ₹2,429.70 lakh proceeds unutilised, with plant & machinery at ₹0, and issue expenses overran allocation by ₹21.51 lakh
- Shiprocket/Growth Capex Gap↓ [MEDIUM RISK]▼
No IPO funds deployed to platform growth, marketing or technology, with ₹210 Cr (≈24% of ₹885.50 Cr) used only for debt repayment, and a Company Secretary resignation effective November 5, 2026
- Anand Seamless/Full Unutilised Balance↓ [LOW-MEDIUM RISK]▼
Entire ₹2,551.68 lakh raise sits unutilised, and the monitoring agency is not applicable, reducing external oversight
Opportunities (7)
- Omnitech Engineering/Deployment Catalyst↓ (OPPORTUNITY)◆
With 52.9% (₹2,080.94 mn) still to deploy into new-facility capex and solar installation, incremental capex execution could lift asset-based revenue visibility over the coming quarters
- AhaSolar Technologies/Operating Inflection↓ (OPPORTUNITY)◆
Operating profit swung from a loss of ₹31.17 lakh to ₹65.19 lakh and PP&E rose to ₹710.92 lakh from ₹60.08 lakh as CWIP was capitalised, pointing to commissioned capacity earning returns
- Quanto Agroworld/Distillation Plant Restart↓ (OPPORTUNITY)◆
If the ₹379.24 Cr distillation allocation is deployed, the project could add a new value-added revenue stream; monitor the next NSE utilisation statement for first spend
- Harikanta Overseas/Capex Ramp↓ (OPPORTUNITY)◆
₹932.50 lakh of plant & machinery and ₹500 lakh-scale factory capex remain untapped, so a deployment announcement would be a near-term catalyst for capacity additions
- Symbiotec Pharmalab/Debt-Reduction Benefit↓ (OPPORTUNITY)◆
Of ₹150 Cr proceeds, ₹112.50 Cr (75%) is earmarked for prepayment of borrowings, which should lower interest costs and improve net-profit conversion once executed
- Scan Steels/Direct NSE Listing Liquidity↓ (OPPORTUNITY)◆
Board-approved direct listing of existing equity shares on NSE broadens the investor base and could improve trading liquidity for a company with ~34% QoQ revenue volatility
- Shiprocket/Deleveraging Re-rating↓ (OPPORTUNITY)◆
Repaying ₹210 Cr of bank debt from IPO proceeds reduces leverage ahead of growth deployment, supporting a balance-sheet re-rating case if growth spend follows
Sector Themes (5)
- Slow IPO Proceed Deployment (HIGH IMPLICATION)◆
Of nine filings, at least five (Quanto, Harikanta, Anand Seamless, Yatharth, Shiprocket) show material unutilised balances, with Quanto ₹1,515 Cr and Anand Seamless 100% unspent; deployment lag is the dominant cross-filing pattern
- Deleveraging via IPO Proceeds (MEDIUM IMPLICATION)◆
Shiprocket (₹210 Cr) and Symbiotec (₹112.50 Cr of ₹150 Cr) both direct a large share of proceeds to repaying borrowings, implying balance-sheet repair is a primary IPO use case in this cohort
- Other-Income-Driven Profitability (MEDIUM IMPLICATION)◆
Scan Steels' profit (other income ~82% of net profit) and AhaSolar's first positive operating result highlight that headline earnings in newly listed small caps often need quality-of-earnings scrutiny
- Governance Hygiene Is Generally Strong (LOW-MEDIUM IMPLICATION)◆
Omnitech, Symbiotec, and Harikanta all confirm no deviations from objects and Audit Committee/Board review, while Anand Seamless has auditor certification; disclosure discipline is consistent even where deployment lags
- Working-Capital Stress in Small Issuers (MEDIUM IMPLICATION)◆
AhaSolar's negative operating cash flow with rising short-term debt and Harikanta's undeployed cash parked in liquid funds suggest some SME issuers are funding operations from debt rather than IPO capital
Watch List (8)
-
Next NSE utilisation statement for first spend on the ₹379.24 Cr distillation plant and any reallocation from the ₹465.00 Cr GCP bucket [next quarterly statement]
-
Progress toward the March 31, 2027 utilisation deadline across subsidiaries; a further extension would be a material negative signal [by March 31, 2027]
-
Completion of the NSE direct listing and sustainability of operating profit excluding other income of ~₹1,194.80 lakh in the next quarter [Q3 FY27 results]
-
Cash burn trajectory and whether short-term borrowings of ₹182.90 lakh are rolled or repaid; watch operating cash flow turn [Q3 FY27 results]
-
Deployment of the remaining ~₹675.50 Cr of IPO proceeds toward growth, marketing and technology, plus the Company Secretary transition from Anil Kumar effective November 6, 2026 [next monitoring report]
-
Whether ₹932.50 lakh plant & machinery allocation begins deployment, given zero spend so far [next half-year statement]
-
First utilisation disclosure after the September 29, 2026 listing, given the entire ₹2,551.68 lakh is currently unspent and no monitoring agency applies [next Regulation 32 statement]
-
Pace of deployment of the remaining ₹2,080.94 mn toward new facilities and solar capex, with the next CRISIL monitoring report [next quarterly report]
Filing Analyses
(9)
05-11-2026
Scan Steels Limited's board approved unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026, and approved a direct listing of its existing equity shares on NSE. Q2 FY27 revenue from operations was ₹17043.87 Lacs, down 34% from Q1 FY27 (₹25778.84 Lacs) but up 28% YoY from ₹13295.69 Lacs; net profit was ₹1452.59 Lacs versus a loss of ₹24.73 Lacs in the year-ago quarter, though approximately ₹1196.16 Lacs of the quarter's profit came from other income.
- · Q2 FY27 profit was heavily supported by other income of ₹1194.80 Lacs, versus ₹6.29 Lacs a year earlier; operating profit quality is weaker than the headline net profit suggests
- · Q2 FY27 total expenses rose 22.2% YoY to ₹16298.70 Lacs, outpacing the 28.2% revenue growth only modestly, with finance costs up to ₹242.15 Lacs from ₹216.84 Lacs
- · Q2 FY26 posted a net loss of ₹24.73 Lacs, so the YoY swing to profit is driven by the sharp revenue recovery and the large other income contribution
- · Inventories rose to ₹17302.19 Lacs from ₹16811.80 Lacs and trade receivables increased 53.5% to ₹3239.07 Lacs since March 2026, signalling working capital build-up
- · Net cash from operating activities was only ₹431.68 Lacs in H1 FY27, versus an outflow of ₹2155.92 Lacs in H1 FY26; the improvement is partly offset by heavy capex of ₹1925.43 Lacs
- · Borrowings increased materially: non-current borrowings of ₹2083.04 Lacs were newly raised, and short-term borrowings rose to ₹7868.46 Lacs
- · Paid-up equity share capital increased to ₹6074.65 Lacs from ₹5860.23 Lacs, and instruments entirely equity in nature (₹204.21 Lacs) were eliminated
- · Board meeting commenced at 4:00 PM and concluded at 5:40 PM on November 5, 2026; statutory auditors issued a Limited Review Report on the results
- · Financial results to be published in newspapers under Regulation 47 of SEBI Listing Regulations; results also available on the company website and BSE website
05-11-2026
Yatharth Hospital & Trauma Care Services Limited filed a Monitoring Agency Report from CARE Ratings for the quarter ended September 30, 2026, regarding the utilization of its ₹569.71 crore IPO proceeds. The report confirms no deviation from the stated objects, but reveals that a significant portion of funds remained unutilized, leading the company to seek and receive shareholder approval at the AGM on September 25, 2026, for an extension of the utilization deadline to March 31, 2027, and a revision in the scope of fund usage to include all subsidiaries.
- · The Monitoring Agency Report was issued by CARE Ratings Limited, appointed as per the Monitoring Agency Agreement dated July 15, 2023.
- · The Audit Committee reviewed and took note of the report in its meeting held on November 03, 2026.
- · Shareholder approval for the extension of the fund utilization deadline to March 31, 2027, and revision in scope was obtained at the AGM dated September 25, 2026.
- · For Item 2 (repayment of subsidiary borrowings), no utilization was made during Q2 FY27, leaving ₹142.72 crore unutilized out of the proposed ₹145.00 crore.
- · The CA certificate from M S K A & Associates (Statutory Auditor) dated October 28, 2026, provides 'limited assurance' regarding the details mentioned therein.
- · The report declares no deviation from the objects and no material deviation requiring shareholder approval beyond what was already obtained.
05-11-2026
Omnitech Engineering Ltd filed the Monitoring Agency Report from Crisil Ratings for the quarter ended September 30, 2026, regarding utilization of its ₹4,180.00 million IPO proceeds. As of quarter-end, ₹1,851.50 million (47.1%) of the net proceeds have been utilized, while ₹2,080.94 million (52.9%) remain unutilized. The funds are being deployed towards capital expenditure at new facilities, solar panel installation, and general corporate purposes, with no deviations from the objects stated in the offer document.
- · No deviations from the objects of the issue were observed.
- · The Audit Committee and Board of Directors approved the report on November 4, 2026.
- · During the quarter ended June 30, 2026, a reconciliation of issue expenses resulted in a downward revision from ₹366.25 million to ₹345.29 million, creating a surplus of ₹20.96 million. Of this, ₹15.03 million was reallocated to General Corporate Purposes and ₹5.93 million was refunded to Selling Shareholders.
- · The actual issue expenses attributable to Selling Shareholders were ₹97.73 million against an estimated ₹103.66 million, resulting in a refund of ₹5.93 million.
- · For Facility 1, ₹302.77 million has been utilized out of ₹1,328.44 million proposed, with ₹1,025.67 million unutilized.
- · For Facility 2, ₹236.80 million has been utilized out of ₹1,007.14 million proposed, with ₹770.34 million unutilized.
- · For solar panels/equipment at Existing Facility 2, ₹152.24 million has been utilized out of ₹186.98 million proposed, with ₹34.74 million unutilized.
- · For General Corporate Purposes, ₹659.69 million has been utilized out of ₹909.88 million revised allocation, with ₹250.19 million unutilized.
- · Issue expenses of ₹223.56 million have been paid out of ₹247.56 million, with ₹24.00 million pending crystallization.
05-11-2026
Harikanta Overseas Ltd filed a statement with BSE confirming no deviation or variation in the use of IPO proceeds of ₹2,429.70 lakh for the half year ended 30th September 2026. While the company has fully utilized funds for working capital (₹475.00 lakh) and issue expenses (₹351.11 lakh), it has significantly underutilized funds for factory premises capital expenditure (₹40.00 lakh utilized out of ₹540.35 lakh) and plant & machinery (₹0 utilized out of ₹932.50 lakh), with total unutilized funds of ₹1,541.69 lakh temporarily parked in bank deposits and liquid funds. Additionally, issue expenses exceeded the original allocation by ₹21.51 lakh, which was adjusted against the general corporate purposes allocation.
- · The IPO was a book-building issue under SEBI ICDR Regulations, 2018.
- · Equity shares were listed on BSE SME platform on 2nd June 2026.
- · The Audit Committee and Board reviewed the deviation statement on 5th November 2026.
- · No monitoring agency was appointed for the IPO proceeds.
- · Unutilized funds are temporarily parked in bank accounts, fixed deposits, liquid funds, and mutual funds.
05-11-2026
Quanto Agroworld Limited submitted a statement to the NSE on 04-11-2026 on utilisation of its IPO proceeds, as of 30 September 2026, with an independent chartered accountant's utilisation certificate attached. Of total issue proceeds of ₹3102.10 Crore (per the Prospectus dated 08 September 2026), ₹1586.81 Crore (about 51%) has been utilised and ₹1515.29 Crore remains unutilised. Utilisation is well behind plan for the distillation plant (nil spent against ₹379.24 Crore) and for general corporate purposes (₹10.22 Crore spent against ₹465.00 Crore), while the farm expansion and debt prepayment objects are largely deployed.
- · Distillation plant capex (₹379.24 Crore allocated) shows zero utilisation as of 30-09-2026
- · General corporate purposes (₹465.00 Crore allocated) shows only ₹10.22 Crore utilised, about 2.2%
- · Farm expansion utilised ₹853.22 Crore of ₹1522.94 Crore allocated, about 56%
- · Unutilised amounts are stated exclusive of GST; the statement cites the Prospectus dated 08 September 2026
- · The utilisation certificate was issued under SEBI and BSE fund-utilisation requirements, with the auditor providing reasonable assurance on the books of account
05-11-2026
AHASOLAR TECHNOLOGIES LIMITED reported consolidated net sales of Rs. 6,702.94 Lakhs for the half year ended September 30, 2026, versus Rs. 3,602.36 Lakhs in the half year ended September 30, 2025, an increase of roughly 86%. Net profit rose to Rs. 47.19 Lakhs from a loss of Rs. 11.53 Lakhs in the prior-year half, while the company's Rs. 308.23 Lakh paid-up equity capital was unchanged. Cash and cash equivalents declined sharply to Rs. 46.86 Lakhs from Rs. 248.34 Lakhs at March 31, 2026, and operating cash flow was negative at Rs. (240.45) Lakhs.
- · Operating profit before other income, finance costs and exceptional items was Rs. 65.19 Lakhs versus a loss of Rs. (31.17) Lakhs in the prior-year half
- · Total borrowings (short-term) rose to Rs. 182.90 Lakhs from Rs. 86.03 Lakhs at March 31, 2026
- · Property, plant and equipment rose to Rs. 710.92 Lakhs from Rs. 60.08 Lakhs, while Capital Work in Progress fell to Rs. 7.12 Lakhs from Rs. 690.45 Lakhs, indicating capitalization of prior-period capex
- · Employee benefits expense rose 17.6% year-on-year to Rs. 317.01 Lakhs, and purchase of stock in trade rose 91.3% to Rs. 6,106.63 Lakhs, reflecting thinner margins on the revenue growth
- · Inventories increased to Rs. 126.04 Lakhs from Rs. 22.63 Lakhs and trade receivables increased to Rs. 561.12 Lakhs from Rs. 380.52 Lakhs, tying up working capital
- · Subsidiary RTC Energy Private Limited's financials were not reviewed by the statutory auditor, though the auditor stated its opinion is not modified
- · Cash flow statement and balance sheet cash figures differ (Rs. 41.44 Lakhs vs Rs. 46.86 Lakhs), with the difference attributed to fixed deposits maturing beyond 3 months
05-11-2026
Anand Seamless Limited has filed its Regulation 32 statement confirming no deviation or variation in the utilization of IPO proceeds for the half year ended September 30, 2026. The company raised Rs. 2551.68 Lakhs through its Initial Public Offer, which was allotted on September 25, 2026 and listed on September 29, 2026. The statutory auditor, Chirag R. Shah & Associates, has certified the utilization position.
- · Total IPO allocation of Rs. 2551.68 Lakhs comprises Rs. 1319.78 Lakhs for capacity expansion and operations, Rs. 549.19 Lakhs for debt repayment, Rs. 312.72 Lakhs for issue expenses and Rs. 369.99 Lakhs for general corporate purposes
- · As of September 30, 2026, none of the allocated IPO amounts were utilised, so the entire Rs. 2551.68 Lakhs remains unutilised
- · Monitoring agency is not applicable for this issue
- · Auditor's certificate notes that out of the total amount, Rs. 2.304 Lakhs was received on a date partially illegible in the source document
- · The company's registered office and plant are located at Ankhol Patiya, Chhatral-Kadi Road, Mehsana, Gujarat, and the company holds ISO 9001, ISO 14001 and ISO 45001 certifications
05-11-2026
Symbiotec Pharmalab Ltd filed a Monitoring Agency Report from CARE Ratings for the quarter ended September 30, 2026, covering utilisation of its IPO proceeds aggregating Rs.150 crore. The report states there were no deviations from the stated objects of the issue and no deviation range applies. The filing is a routine regulatory compliance disclosure with no adverse findings.
- · Proceeds allocation: Rs.112.50 Cr for prepayment/repayment of borrowings, Rs.29.53 Cr for general corporate purposes, and Rs.7.98 Cr for offer-related expenses; no cost revisions reported.
- · Monitoring Agency Agreement dated August 06, 2026; CA certificate from Mahesh C Solanki & Co. (peer-reviewed audit firm) dated November 2, 2026, served as the source of utilisation information.
- · Management certified there is no other relevant information that may materially affect investor decision-making.
05-11-2026
Shiprocket Ltd's board approved unaudited financial results for Q2 FY27 and noted the first monitoring agency report for its ₹885.50 Cr IPO proceeds. The company fully utilized ₹210.00 Cr of IPO funds to repay borrowings (₹133.50 Cr to HDFC Bank and ₹76.50 Cr to ICICI Bank), but no funds were deployed toward platform growth, marketing, or technology initiatives during the quarter. Additionally, Company Secretary Nikhil Kumar resigned effective November 5, 2026, and Anil Kumar was appointed as his successor effective November 6, 2026.
- · The board meeting commenced at 10:20 AM IST and concluded at 11:17 AM IST on November 5, 2026.
- · Nikhil Kumar's resignation as Company Secretary and Compliance Officer was effective from close of business on November 5, 2026.
- · Anil Kumar's appointment as Company Secretary and Compliance Officer (KMP) is effective from November 6, 2026.
- · No deviation from the objects of the IPO was reported by the monitoring agency.
- · The monitoring agency confirmed no change in means of finance and no major deviation from earlier reports (this being the initial report).
Get daily alerts with 10 investment signals, 8 risk alerts, 7 opportunities and full AI analysis of all 9 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India IPO SEBI DRHP Activity Filings
🇮🇳 More from India
View all →November 06, 2026
India Pre-Market Regulatory Roundup — November 06, 2026
India Pre-Market Regulatory Roundup
November 06, 2026
India Quarterly Results BSE NSE Announcements — November 06, 2026
India Quarterly Results BSE NSE Announcements
November 06, 2026
India Upcoming Corporate Actions BSE NSE — November 06, 2026
India Upcoming Corporate Actions BSE NSE
November 06, 2026
India RBI Monetary Policy Repo Rate Decisions — November 06, 2026
India RBI Monetary Policy Repo Rate Decisions